Pharmaceuticals policy http://www.globalpost.com/taxonomy/term/31133/all en Buyers eye multibillion deal for Brazilian drugmaker -sources http://www.globalpost.com/dispatch/news/thomson-reuters/130207/buyers-eye-multibillion-deal-brazilian-drugmaker-sources <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>* Lazard's Brazilian arm hired to investigate sale</p> <p>* Ache ranks as market leader in prescription drugs</p> <p>* Differing views among owners mean sale uncertain</p> <p>By Ben Hirschler and Sophie Sassard</p> <p>Feb 7 (Reuters) - International drug companies are considering bidding for Ache Laboratorios Farmaceuticos, one of Brazil's biggest drugmakers, in a deal valuing it at several billion dollars, according to people involved in the process.</p> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130207/buyers-eye-multibillion-deal-brazilian-drugmaker-sources" target="_blank">read more</a></p> Business Health Labor Pharmaceutical sciences Pharmaceuticals policy Pharmacology Social Issues Thomson Reuters Thu, 07 Feb 2013 18:45:41 +0000 Thomson Reuters 5749248 at http://www.globalpost.com US experts press for tough tack on fake medicines http://www.globalpost.com/dispatch/news/afp/130213/us-experts-press-tough-tack-fake-medicines <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>Health experts are urging the United States and other countries to boost their ability to identify fake or subpar medicines and close loopholes that allow products to be falsified or diluted.</p> <p>In an international system in which different companies in many countries make ingredients for single treatments, no country alone can effectively enforce quality control on drugs that can be the fine line between life and death, stressed a report by the independent Institute of Medicine (IOM).</p> <p><a href="http://www.globalpost.com/dispatch/news/afp/130213/us-experts-press-tough-tack-fake-medicines" target="_blank">read more</a></p> Business Education Health Labor Pharmaceutical sciences Pharmaceuticals policy Pharmacology Politics Social Issues Technology AFP Wed, 13 Feb 2013 16:31:51 +0000 Agence France-Presse 5754729 at http://www.globalpost.com Interpol deal with drug firms to fight fake medicines http://www.globalpost.com/dispatch/news/afp/130312/interpol-deal-drug-firms-fight-fake-medicines <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>Interpol on Tuesday announced a deal with the world's top pharmaceutical companies to fight fake drugs which threaten the health of millions, especially in poor countries.</p> <p>Twenty-nine leading companies have pledged 4.5 million euros ($5.9 million) over three years to improve the fight against the counterfeit industry, boost public awareness and crack down on illegal manufacturers.</p> <p><a href="http://www.globalpost.com/dispatch/news/afp/130312/interpol-deal-drug-firms-fight-fake-medicines" target="_blank">read more</a></p> Counterfeit consumer goods INTERPOL Pharmaceutical sciences Pharmaceuticals policy AFP Tue, 12 Mar 2013 15:46:49 +0000 Agence France-Presse 5781122 at http://www.globalpost.com NK-humanitarian aid http://www.globalpost.com/dispatch/news/yonhap-news-agency/130321/nk-humanitarian-aid-0 <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Yonhap News Agency </div> </div> </div> <!--paging_filter--><p>SEOUL, March 22 (Yonhap) -- South Korea approved Friday the first shipment of humanitarian aid by a private charity group to North Korea since President Park Geun-hye took office last month.</p> <p>"This latest approval was given for the pure humanitarian need to help tuberculosis patients in North Korea," unification ministry spokesman Kim Hyung-suk said.</p> <p><a href="http://www.globalpost.com/dispatch/news/yonhap-news-agency/130321/nk-humanitarian-aid-0" target="_blank">read more</a></p> Antibiotic-resistant bacteria Pharmaceuticals policy Tuberculosis Yonhap News Agency Fri, 22 Mar 2013 03:16:13 +0000 Yonhap News Agency 5790598 at http://www.globalpost.com India top court to deliver key drug patent ruling http://www.globalpost.com/dispatch/news/afp/130331/india-top-court-deliver-key-drug-patent-ruling <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>India's Supreme Court is set to rule Monday on a patent challenge by Swiss drug giant Novartis that activists say threatens access to cheap generic versions of life-saving drugs in developing nations.</p> <p>The landmark case -- watched closely by global drug firms and patient groups -- involves an updated version of Novartis' blockbuster cancer drug Glivec, for which the company has fought a seven-year legal battle to win patent protection.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.afp.com/" class="button wire afp"></a></p> <p><a href="http://www.globalpost.com/terms-use#afp"><span>Copyright AFP, 2013.</span></a></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/afp/130331/india-top-court-deliver-key-drug-patent-ruling" target="_blank">read more</a></p> Business Hospitality Law Patent law Pharmaceutical sciences Pharmaceuticals policy Politics Social Issues AFP Sun, 31 Mar 2013 21:30:47 +0000 Agence France-Presse 5798259 at http://www.globalpost.com India's top court backs generics in key drug patent ruling http://www.globalpost.com/dispatch/news/afp/130401/indias-top-court-backs-generics-key-drug-patent-ruling <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>India's Supreme Court rejected Monday a patent bid by Swiss drug giant Novartis, in a landmark ruling that activists say will protect access to cheap generic versions of drugs in developing nations.</p> <p>Novartis fought a seven-year legal battle to gain patent protection for an updated version of its blockbuster cancer drug Glivec, arguing that the compound was a significant improvement because it is more easily absorbed by the body.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.afp.com/" class="button wire afp"></a></p> <p><a href="http://www.globalpost.com/terms-use#afp"><span>Copyright AFP, 2013.</span></a></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/afp/130401/indias-top-court-backs-generics-key-drug-patent-ruling" target="_blank">read more</a></p> Business Hospitality Law Patent law Pharmaceutical sciences Pharmaceuticals policy Politics Social Issues AFP Mon, 01 Apr 2013 06:16:35 +0000 Agence France-Presse 5798413 at http://www.globalpost.com India's top court backs generics in key drug patent ruling http://www.globalpost.com/dispatch/news/afp/130401/indias-top-court-backs-generics-key-drug-patent-ruling-1 <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>India's Supreme Court rejected Monday a patent bid by Swiss drug giant Novartis in a landmark ruling that activists say will protect cheap generic drugs and save lives in developing nations.</p> <p>Novartis fought a seven-year legal battle to gain patent protection for an updated version of its blockbuster leukaemia drug Glivec, arguing the compound was a significant improvement because it is more easily absorbed by the body.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.afp.com/" class="button wire afp"></a></p> <p><a href="http://www.globalpost.com/terms-use#afp"><span>Copyright AFP, 2013.</span></a></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/afp/130401/indias-top-court-backs-generics-key-drug-patent-ruling-1" target="_blank">read more</a></p> Business Hospitality Law Patent law Pharmaceutical sciences Pharmaceuticals policy Politics Social Issues AFP Mon, 01 Apr 2013 11:30:53 +0000 Agence France-Presse 5798526 at http://www.globalpost.com Indian high court rules against drug company in patent fight http://www.globalpost.com/dispatch/news/agencia-efe/130401/indian-high-court-rules-against-drug-company-patent-fight <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agencia EFE </div> </div> </div> <!--paging_filter--><p>New Delhi, Apr 1 (EFE).- Swiss-based pharmaceutical giant Novartis AG saw its bid to patent a new version of a cancer medication blocked on Monday by the Indian Supreme Court.</p> <p>The judges agreed with activists and generic drug makers that the changes to cancer drug Glivec were not of sufficient magnitude to justify treating it as a new medication.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.efe.com" class="button wire efe"></a></p> <p><a href="http://www.globalpost.com/terms-use#efe"><span>Copyright EFE, 2013.</span></a></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/agencia-efe/130401/indian-high-court-rules-against-drug-company-patent-fight" target="_blank">read more</a></p> Business Hospitality Law Novartis Pharmaceutical sciences Pharmaceuticals policy Politics Agencia EFE Mon, 01 Apr 2013 22:30:50 +0000 Agencia EFE 5798864 at http://www.globalpost.com Analysis - Big Pharma down, not out, after Indian patent blow http://www.globalpost.com/dispatch/news/thomson-reuters/130402/analysis-big-pharma-down-not-out-after-indian-patent-blow <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>By Ben Hirschler and Kaustubh Kulkarni</p> <p>LONDON/MUMBAI (Reuters) - Stung by a landmark patent defeat, Western drugmakers will be wary about launching new products in India, but they cannot afford to quit a country tipped to be the world's eighth largest market for medicines by 2016.</p> <p>Makers of patented drugs will in future have to get more creative about doing business in India, including striking deals with local firms to sell cheaper versions of their drugs, industry experts believe.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://thomsonreuters.com" class="button wire reuters"></a></p> <p><span>Copyright Thomson Reuters, 2013.</span></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130402/analysis-big-pharma-down-not-out-after-indian-patent-blow" target="_blank">read more</a></p> Business Health Hospitality Labor Law Pharmaceutical sciences Pharmaceuticals policy Pharmacology Politics Social Issues Thomson Reuters Tue, 02 Apr 2013 15:46:11 +0000 Thomson Reuters 5799536 at http://www.globalpost.com Fabupharm doubles in size http://www.globalpost.com/dispatch/news/asianet/130409/fabupharm-doubles-size <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Asianet </div> </div> </div> <!--paging_filter--><p></p><P> Fabupharm Products, a 100 per cent Namibian pharmaceutical manufacturer is now able to manufacture registered medicinal products. </p><P>The company announced in a media statement issued on Friday that it has received an Official Manufacturing GMP (Good Manufacturing Practice) License from the Namibian Medicines Regulatory Council (NMRC).</p> <p><a href="http://www.globalpost.com/dispatch/news/asianet/130409/fabupharm-doubles-size" target="_blank">read more</a></p> Business Fabupharm Products Fanie Badenhorst Human Interest Labor Law Pharmaceutical sciences Pharmaceuticals policy Pharmacology Asianet Tue, 09 Apr 2013 08:03:14 +0000 Asianet 5806473 at http://www.globalpost.com J&J tops estimates on strong prescription drug sales http://www.globalpost.com/dispatch/news/thomson-reuters/130416/jj-tops-estimates-strong-prescription-drug-sales <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>By Ransdell Pierson</p> <p>(Reuters) - Johnson &amp; Johnson beat Wall Street's quarterly profit estimates on sharply lower taxes, strong sales of prescription drugs and a revival of over-the-counter medicines that had been recalled over quality control problems.</p> <p>But sales growth for J&amp;J's &lt;JNJ.N&gt; medical devices fell short of expectations in the first quarter, and the diversified healthcare company said on Tuesday it took a big charge for product-liability litigation.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://thomsonreuters.com" class="button wire reuters"></a></p> <p><span>Copyright Thomson Reuters, 2013.</span></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130416/jj-tops-estimates-strong-prescription-drug-sales" target="_blank">read more</a></p> Health Labor Medicine Pharmaceuticals policy Social Issues Thomson Reuters Tue, 16 Apr 2013 14:45:04 +0000 Thomson Reuters 5817412 at http://www.globalpost.com J&J tops estimates as prescription, OTC drugs shine http://www.globalpost.com/dispatch/news/thomson-reuters/130416/jj-tops-estimates-prescription-otc-drugs-shine <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>By Ransdell Pierson</p> <p>(Reuters) - Johnson &amp; Johnson beat Wall Street's quarterly profit estimates on sharply lower taxes, strong sales of prescription drugs and a revival of over-the-counter medicines that had been recalled over quality control problems.</p> <p>Newer prescription medicines, including prostate cancer drug Zytiga, psoriasis drug Stelara, and Incivo for hepatitis C made big contributions.</p> <p>J&amp;J shares rose 1.7 percent to $83.13 in mid-day trading.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://thomsonreuters.com" class="button wire reuters"></a></p> <p><span>Copyright Thomson Reuters, 2013.</span></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130416/jj-tops-estimates-prescription-otc-drugs-shine" target="_blank">read more</a></p> Medicine Pharmaceuticals policy Pharmacology Thomson Reuters Tue, 16 Apr 2013 16:45:19 +0000 Thomson Reuters 5817553 at http://www.globalpost.com CVS Caremark's 1st quarter profit jumps 23 per cent, helped by impact from generic drugs http://www.globalpost.com/dispatch/news/the-canadian-press/130501/cvs-caremarks-1st-quarter-profit-jumps-23-cent-helped-impact <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> The Canadian Press </div> </div> </div> <!--paging_filter--><p>CVS Caremark's first-quarter net income jumped 23 per cent to top Wall Street's expectations, as generic drugs continued to improve profitability even though those prescriptions hurt revenue.</p> <p>Generic drugs, which are cheaper, copycat versions of brand-name medicines, help a drugstore's bottom line because they provide a wider margin between the cost for the pharmacy to purchase the drugs and the reimbursement received. But they hurt drugstore revenue because generics cost less than brand-name drugs.</p> <p><a href="http://www.globalpost.com/dispatch/news/the-canadian-press/130501/cvs-caremarks-1st-quarter-profit-jumps-23-cent-helped-impact" target="_blank">read more</a></p> Business Caremark Rx CVS Caremark CVS Caremark CVS Caremark Corp. Health Labor Law Pharmaceutical sciences Pharmaceuticals policy Pharmacology Providence County, Rhode Island Social Issues The Canadian Press Wed, 01 May 2013 12:30:20 +0000 The Canadian Press 5829166 at http://www.globalpost.com Jean Coutu says Alberta drug price cuts will prompt another such wave in Quebec http://www.globalpost.com/dispatch/news/the-canadian-press/130501/jean-coutu-ups-dividend-214-cent-shorter-q4-period-lowers-pr <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> The Canadian Press </div> </div> </div> <!--paging_filter--><p>MONTREAL - Jean Coutu's chief executive says growing sales from generic drugs will help to compensate for another wave of provincial price reductions.</p> <p>"Obviously, we're not in complete control as governments are controlling the pricing, but at the same time, I think there will be light at the end of the tunnel somehow for everyone in the industry," CEO Francois Coutu said Wednesday during a conference call.</p> <p><a href="http://www.globalpost.com/dispatch/news/the-canadian-press/130501/jean-coutu-ups-dividend-214-cent-shorter-q4-period-lowers-pr" target="_blank">read more</a></p> Business Economy of Canada Franchises Jean Coutu Group Pharmaceuticals policy S&P/TSX Composite Index The Jean Coutu Group Inc. The Canadian Press Wed, 01 May 2013 13:45:21 +0000 The Canadian Press 5829217 at http://www.globalpost.com Pfizer sells Viagra on its website in a drug industry first http://www.globalpost.com/dispatch/news/the-canadian-press/130506/pfizer-sells-viagra-its-website-drug-industry-first <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> The Canadian Press </div> </div> </div> <!--paging_filter--><p>TRENTON, N.J. - Men who are bashful about needing help in the bedroom no longer have to go to the drugstore to buy that little blue pill.</p> <p>In a first for the drug industry, Pfizer Inc. told The Associated Press that the drugmaker will begin selling its popular erectile dysfunction pill Viagra directly to patients on its website.</p> <p><a href="http://www.globalpost.com/dispatch/news/the-canadian-press/130506/pfizer-sells-viagra-its-website-drug-industry-first" target="_blank">read more</a></p> Chemistry Health Labor Pharmaceutical sciences Pharmaceuticals policy Pharmacology Social Issues Technology Viagra The Canadian Press Mon, 06 May 2013 07:45:04 +0000 The Canadian Press 5831639 at http://www.globalpost.com